Navigation Links
Melanoma-initiating cell identified by Stanford scientists
Date:6/30/2010

ximilian Diehn, MD, PhD, in collaboration with the laboratories of Weissman and Stanford colleague Michael Clarke, MD, have indicated that cancer stem cells may be more resistant than other cancer cells to many common treatments like radiation and some chemotherapies. Clarke is the Karel H. and Avice N. Beekhuis Professor in Cancer Biology at the medical school and both Diehn and Clarke are members of the Stanford Cancer Center.

Although a growing body of evidence seems to support the cancer stem cell hypothesis, melanoma has remained a conundrum. A University of Michigan study in 2008 found that as many as one in four melanoma cells could cause cancers in immune compromised mice, suggesting that there may not be a particularly privileged subset of cancer stem cells in this tumor type. Boiko set out to solve the mystery.

"I didn't know if melanoma would in fact have the cancer-initiating cells," said Boiko. "I was completely unbiased, so I was actually sort of surprised to find such a clear-cut answer. It fits exactly what's been discovered in the studies of other solid tumors."

To conduct the study, Boiko analyzed cell surface markers on primary melanoma tumor samples taken directly from patients at the Stanford Cancer Center. In this way, he avoided having to grow the cells for a long period of time in the lab. Continuous culturing, or passage, of cancer cells often gives the cells time to evolve and change in ways that might not accurately reflect their composition in melanoma patients.

He found that one protein, called CD271, was always expressed on only a fraction of the cells in the human melanoma samples tested: The proportion of cells expressing CD271 varied in the samples from 2.5 to 41 percent of the total cell population; the marker appeared on a mean of 16.7 percent of cells in the samples.

This was interesting because CD271 was previously identified as a marker that identifies a group of cells called the n
'/>"/>

Contact: Krista Conger
kristac@stanford.edu
650-725-5371
Stanford University Medical Center
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Mechanism that may trigger degenerative disease identified
2. New Alzheimers Risk Genes Identified
3. Strange Artifact Identified as Ancient Anti-Snoring Device
4. New Alzheimers Gene Identified
5. Newly identified proteins critical to FA pathway DNA repair function
6. Gene Mutations Identified for Charcot-Marie-Tooth Syndrome
7. Salmonella Tennessee Identified in a Processed Food Ingredient
8. Predisposing factors for conversion of mild cognitive impairment to AD identified
9. Meat Might Be Behind Many Unidentified Allergic Reactions
10. Damaged protein identified as early diagnostic biomarker for Alzheimers disease in healthy adults
11. Tumor mechanism identified
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... ... ... Illinois Health & Science (IHS) has completed the purchase of IBA Molecular ... IBAM NA’s cyclotron sites and research and development facilities. , “We are ... as a large manufacturing hub in Noblesville, Indiana,” said Ken Smithmier, President and CEO ...
(Date:8/3/2015)... ... 2015 , ... Dignity Health named Dr. Norris A. Baldwin, Jr. the Facility ... opening in August. The new facility is licensed under Dignity Health Arizona ... “Dr. Baldwin is an excellent leader and will ensure our new freestanding emergency room ...
(Date:8/3/2015)... ... August 03, 2015 , ... ... firm, announced today that Joe Williams has joined its growing California employee benefits ... HUB's differentiated service model to his clients. Mr. Williams will be joining the ...
(Date:8/3/2015)... Miami, Florida (PRWEB) , ... August 03, 2015 , ... ... neuropathy pain accompanied by tissue injury caused by diabetes after many years of suffering ... work many times, and he didn’t want to ask for extra time off or ...
(Date:8/3/2015)... ... 03, 2015 , ... Cambia Health Solutions has promoted Scott ... company’s Medicare and Federal Employee Programs (FEP) lines of business. , Government ... members. In this role, Scott is responsible for overseeing the growth, finance and ...
Breaking Medicine News(10 mins):Health News:Illinois Health & Science Expands Nuclear Medicine Footprint With Purchase of IBA Molecular North America, Inc. 2Health News:Dignity Health Names Dr. Norris A. Baldwin, Jr. Facility Medical Director of New Freestanding Emergency Room 2Health News:Dignity Health Names Dr. Norris A. Baldwin, Jr. Facility Medical Director of New Freestanding Emergency Room 3Health News:HUB International Insurance Services Announces Joe Williams Has Joined its Northern California Employee Benefits Division 2Health News:Chinese Health Care Provider Heshoutang Now Give Patients Complimentary Online Healing Options 2Health News:Chinese Health Care Provider Heshoutang Now Give Patients Complimentary Online Healing Options 3Health News:Cambia Health Solutions Names Scott Powers President of Government Programs 2
... Heart Institute is the lead enroller in the world for ... repair for severe mitral valve regurgitation with conventional surgery. In ... first Evalve MitraClip in California, and was also first on ... procedure. Cedars-Sinai is believed to be the most experienced center ...
... debate continues on whether the nutrient should be recommended for ... patients with high blood levels of vitamin D boost their ... , Previous studies have indicated that high levels of vitamin ... 51 percent, although other studies dispute that claim. But until ...
... Senior,Living Inc. (NYSE: BKD ) announced today that ... 2008 Jefferies Healthcare,Conference in New York, New York on ... The presentation is being webcast live and can be ... at, http://www.brookdaleliving.com . A replay of the webcast will ...
... Adds $47 million in annual revenues and eight locations in New ... Connecticut, and ... AFAM ), a leading regional provider of home health nursing,services, ... stock of Patient Care, Inc. This acquisition, the Company,s,largest to date, ...
... Message to Fans, TALLAHASSEE, Fla., June 19 ... top-ranked Florida Marlins and Tampa Bay,Rays are leading a ... Free Florida, an initiative of the Florida Department of,Health, ... Floridians with,its messages of smoking and smokeless tobacco prevention ...
... 19 /PRNewswire-FirstCall/,-- Cord Blood America, Inc. (OTC ... cell preservation company ( http://www.cordblood-america.com ),focused ... stem cells to families,nationwide and internationally, today ... in enacting legislation requiring health care facilities ...
Cached Medicine News:Health News:Evalve MitraClip: Clinical trial of nonsurgical repair for severe mitral valve regurgitation 2Health News:Vitamin D May Promote Colon Cancer Survival 2Health News:Vitamin D May Promote Colon Cancer Survival 3Health News:Almost Family, Inc. Signs Definitive Agreement to Acquire Patient Care, Inc. 2Health News:Almost Family, Inc. Signs Definitive Agreement to Acquire Patient Care, Inc. 3Health News:Almost Family, Inc. Signs Definitive Agreement to Acquire Patient Care, Inc. 4Health News:Rivalry Aside, Marlins and Rays Team Up To Fight Tobacco 2Health News:Cord Blood America Says Pennsylvania Joins New York and California in Informing Parents of the Advantages of Umbilical Cord Blood Storage 2
(Date:8/2/2015)... 3, 2015  Isis Pharmaceuticals, Inc. (NASDAQ: ... collaboration to discover and develop antisense therapies for ... builds on a broad existing relationship between the ... these therapeutic areas using novel RNA-targeted treatments. It ... its antisense technology to diseases of the kidney. ...
(Date:8/2/2015)... -- Mandatory takeover offer for the ... the "Company") is pleased to announce the signing of ... Marijan Han žeković to acquire his 63.3% holding (equivalent ... Croatian listed pharmaceutical business.   Dechra is ... €51.4 million for the entire share capital on a ...
(Date:8/2/2015)... 2015  Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX ... 3 clinical trial met its primary endpoint, showing ... cancer patients with carcinoid syndrome that is not ... Telotristat etiprate was discovered using Lexicon,s gene science, ... company,s first discovery to complete a pivotal Phase ...
Breaking Medicine Technology:AstraZeneca and Isis Pharmaceuticals to Discover and Develop Antisense Drugs for Cardiovascular, Metabolic and Renal Diseases 2AstraZeneca and Isis Pharmaceuticals to Discover and Develop Antisense Drugs for Cardiovascular, Metabolic and Renal Diseases 3AstraZeneca and Isis Pharmaceuticals to Discover and Develop Antisense Drugs for Cardiovascular, Metabolic and Renal Diseases 4Dechra to Acquire 63.3% Shareholding (£19.4m) in Genera d.d. Croatia 2Dechra to Acquire 63.3% Shareholding (£19.4m) in Genera d.d. Croatia 3Dechra to Acquire 63.3% Shareholding (£19.4m) in Genera d.d. Croatia 4Dechra to Acquire 63.3% Shareholding (£19.4m) in Genera d.d. Croatia 5Lexicon Pharmaceuticals Reports Positive Top-Line Results For Pivotal Phase 3 Telotristat Etiprate Study In Cancer Patients With Carcinoid Syndrome 2Lexicon Pharmaceuticals Reports Positive Top-Line Results For Pivotal Phase 3 Telotristat Etiprate Study In Cancer Patients With Carcinoid Syndrome 3Lexicon Pharmaceuticals Reports Positive Top-Line Results For Pivotal Phase 3 Telotristat Etiprate Study In Cancer Patients With Carcinoid Syndrome 4Lexicon Pharmaceuticals Reports Positive Top-Line Results For Pivotal Phase 3 Telotristat Etiprate Study In Cancer Patients With Carcinoid Syndrome 5Lexicon Pharmaceuticals Reports Positive Top-Line Results For Pivotal Phase 3 Telotristat Etiprate Study In Cancer Patients With Carcinoid Syndrome 6
... 16 Westside Medical Associates of Los Angeles ... announce the benefit of early positron emission tomography ... treatable phase. According to Dr. Norman Lepor , Professor of ... and Co-director of Imaging at WMI, "the research investigators at the ...
... American pharmaceutical manufacturer Alpharma Inc. has agreed to pay ... in connection with the marketing of the morphine-based drug, Kadian, ... between January 1, 2000 and December 29, ... to promote or prescribe Kadian, and made misrepresentations about the ...
Cached Medicine Technology:Early Identification of Alzheimer's Disease With PET Scan 2Early Identification of Alzheimer's Disease With PET Scan 3Alpharma to Pay $42.5 Million to Resolve False Claims Act Allegations in Connection With Promotion of Drug Kadian 2Alpharma to Pay $42.5 Million to Resolve False Claims Act Allegations in Connection With Promotion of Drug Kadian 3
... The WideBiter Punch series facilitates fast ... recreating a smooth, anatomically shaped meniscal rim. ... low profile to access even the tightest ... Arthrex California, Inc., 20 years of engineering ...
... The WideBiter Punch series facilitates fast and ... a smooth, anatomically shaped meniscal rim. The ... profile to access even the tightest joint ... California, Inc., 20 years of engineering experience ...
... The WideBiter Punch series facilitates fast and ... a smooth, anatomically shaped meniscal rim. The ... profile to access even the tightest joint ... California, Inc., 20 years of engineering experience ...
... design provides fingertip ratchet disengagement allowing smooth, ... program offers state-of-the-art quality in an instrument ... and durability. Low profile cutting tips allow ... Series I instruments are available in just ...
Medicine Products: